Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($) shares in Thousands, $ in Thousands	Total	Previously Reported	Retroactive application of recapitalization	Common Stock	Common Stock Previously Reported	Common Stock Retroactive application of recapitalization	Additional Paid-In Capital	Additional Paid-In Capital Previously Reported	Additional Paid-In Capital Retroactive application of recapitalization	Accumulated Deficit	Accumulated Deficit Previously Reported	Accumulated Other Comprehensive Loss	Accumulated Other Comprehensive Loss Previously Reported
Beginning balance (in shares) at Dec. 31, 2020	0	102,899	(102,899)
Beginning balance at Dec. 31, 2020	$ 0	$ 287,323	$ (287,323)
Ending balance (in shares) at Mar. 31, 2021	0
Ending balance at Mar. 31, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020				108,697	5,798	102,899
Beginning balance at Dec. 31, 2020	132,682	$ (154,641)	$ 287,323	$ 11	$ 1	$ 10	$ 287,318	$ 5	$ 287,313	$ (154,322)	$ (154,322)	$ (325)	$ (325)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				136
Issuance of common stock upon exercise of stock options	85						85
Stock-based compensation expense	647						647
Other	(16)						(15)			(1)
Comprehensive loss	(22,552)									(22,347)		(205)
Ending balance (in shares) at Mar. 31, 2021				108,833
Ending balance at Mar. 31, 2021	$ 110,846			$ 11			288,035			(176,670)		(530)
Beginning balance (in shares) at Dec. 31, 2020	0	102,899	(102,899)
Beginning balance at Dec. 31, 2020	$ 0	$ 287,323	$ (287,323)
Ending balance (in shares) at Sep. 30, 2021	0
Ending balance at Sep. 30, 2021	$ 0
Beginning balance (in shares) at Dec. 31, 2020				108,697	5,798	102,899
Beginning balance at Dec. 31, 2020	132,682	$ (154,641)	$ 287,323	$ 11	$ 1	$ 10	287,318	$ 5	$ 287,313	(154,322)	$ (154,322)	(325)	$ (325)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss	(84,063)
Ending balance (in shares) at Sep. 30, 2021				178,059
Ending balance at Sep. 30, 2021	$ 289,947			$ 18			528,640			(238,363)		(348)
Beginning balance (in shares) at Mar. 31, 2021	0
Beginning balance at Mar. 31, 2021	$ 0
Ending balance (in shares) at Jun. 30, 2021	0
Ending balance at Jun. 30, 2021	$ 0
Beginning balance (in shares) at Mar. 31, 2021				108,833
Beginning balance at Mar. 31, 2021	110,846			$ 11			288,035			(176,670)		(530)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				581
Issuance of common stock upon exercise of stock options	409						409
Stock-based compensation expense	709						709
Comprehensive loss	(27,291)									(27,419)		128
Ending balance (in shares) at Jun. 30, 2021				109,414
Ending balance at Jun. 30, 2021	$ 84,673			$ 11			289,153			(204,089)		(402)
Ending balance (in shares) at Sep. 30, 2021	0
Ending balance at Sep. 30, 2021	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				251
Issuance of common stock upon exercise of stock options	166						166
Stock-based compensation expense	1,413						1,413
PIPE Investment, net of issuance costs (in shares)				68,069
PIPE Investment, net of issuance costs	233,340			$ 7			233,333
Conversion of warrants into common stock and issuance of equity classified warrants upon Merger (in shares)				325
Conversion of warrants into common stock and issuance of equity classified warrants upon Merger	4,576						4,576
Other	(1)						(1)
Comprehensive loss	(34,220)									(34,274)		54
Ending balance (in shares) at Sep. 30, 2021				178,059
Ending balance at Sep. 30, 2021	$ 289,947			$ 18			528,640			(238,363)		(348)
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Mar. 31, 2022	0
Ending balance at Mar. 31, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021				178,089
Beginning balance at Dec. 31, 2021	251,447			$ 18			533,101			(280,569)		(1,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options and warrants (in shares)				830
Issuance of common stock upon exercise of stock options and warrants	636						636
Stock-based compensation expense	5,683						5,683
PIPE Investment, net of issuance costs (in shares)				26,150
PIPE Investment, net of issuance costs	54,928			$ 3			54,925
Comprehensive loss	(19,200)									(16,576)		(2,624)
Ending balance (in shares) at Mar. 31, 2022				205,069
Ending balance at Mar. 31, 2022	$ 293,494			$ 21			594,345			(297,145)		(3,727)
Beginning balance (in shares) at Dec. 31, 2021	0
Beginning balance at Dec. 31, 2021	$ 0
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Beginning balance (in shares) at Dec. 31, 2021				178,089
Beginning balance at Dec. 31, 2021	251,447			$ 18			533,101			(280,569)		(1,103)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Comprehensive loss	(82,131)
Ending balance (in shares) at Sep. 30, 2022				206,437
Ending balance at Sep. 30, 2022	$ 242,102			$ 21			605,884			(354,868)		(8,935)
Beginning balance (in shares) at Mar. 31, 2022	0
Beginning balance at Mar. 31, 2022	$ 0
Ending balance (in shares) at Jun. 30, 2022	0
Ending balance at Jun. 30, 2022	$ 0
Beginning balance (in shares) at Mar. 31, 2022				205,069
Beginning balance at Mar. 31, 2022	293,494			$ 21			594,345			(297,145)		(3,727)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				547
Issuance of common stock upon exercise of stock options	715						715
Stock-based compensation expense	5,676						5,676
Comprehensive loss	(30,905)									(27,554)		(3,351)
Ending balance (in shares) at Jun. 30, 2022				205,616
Ending balance at Jun. 30, 2022	$ 268,980			$ 21			600,736			(324,699)		(7,078)
Ending balance (in shares) at Sep. 30, 2022	0
Ending balance at Sep. 30, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of stock options (in shares)				727
Issuance of common stock upon exercise of stock options	736						736
Issuance of common stock upon exercise of RSU (in shares)				94
Stock-based compensation expense	4,412						4,412
Comprehensive loss	(32,026)									(30,169)		(1,857)
Ending balance (in shares) at Sep. 30, 2022				206,437
Ending balance at Sep. 30, 2022	$ 242,102			$ 21			$ 605,884			$ (354,868)		$ (8,935)